Related by context. All words. (Click for frequent words.) 73 K ras mutations 72 PARP inhibition 71 KRAS mutations 70 AGTR1 70 promoter methylation 69 VKORC1 69 vimentin 69 prognostic biomarker 69 gene polymorphisms 69 Clusterin 69 tumor histology 69 ERalpha 69 NSCLC tumors 69 mutational status 69 HER2 expression 69 ERBB2 68 estrogen receptor ER 68 carcinoembryonic antigen 68 IL#B 68 chemosensitivity 68 HLA DR4 68 Her2/neu 68 tumorigenicity 68 RRM1 68 TIMP 1 68 thyroid carcinoma 68 MLH1 68 mutated K ras 68 beta1 integrin 68 breast carcinoma 68 gene amplification 68 thyroglobulin 68 MTHFR 68 GSTP1 68 EGFR protein 68 c KIT 68 mRNA expression 68 ABL1 67 EGFR gene 67 constitutively active 67 HER2 amplification 67 Immunohistochemical analysis 67 T#I [002] 67 PTPN# 67 rs# [004] 67 cTnI 67 histological subtype 67 gene polymorphism 67 ABCB1 67 prognostic significance 67 immunoreactivity 67 eosinophil count 67 TIMP 67 cytokeratin 67 HER2 overexpression 67 colorectal carcinomas 67 normal karyotype 67 TOP2A gene 67 miR #a [001] 67 SPINK1 67 variant allele 67 pCR 67 prostate cancer CaP 67 ERCC1 67 microsatellite instability 66 immunohistochemical analysis 66 hormone receptor status 66 selective modulator 66 cisplatin resistant 66 methylation patterns 66 HLA DR2 66 uPAR 66 MSH2 66 SNP rs# [001] 66 activating mutations 66 TNFα 66 cyclin E 66 miRNA expression 66 androgen receptor AR 66 isotype 66 ZNF# 66 prognostic marker 66 HLA DR4 immune 66 Estrogen Receptor 66 tyrosine phosphorylation 66 cell adhesion molecule 66 immunoreactive 66 mTOR inhibitors 66 KRAS mutation 66 C#Y 66 mediated inhibition 66 MGd 66 TRAIL induced apoptosis 66 iNOS 66 deacetylation 66 tryptase 66 inhibin B 66 HER2 receptor 66 multivariable analysis 66 LRP5 65 metastatic malignant 65 gastrointestinal stromal tumors GISTs 65 immunostaining 65 BRCA2 mutation carriers 65 lymph node metastasis 65 pancreatic adenocarcinoma 65 Notch1 65 EGFR mutant 65 EGFR mutations 65 HER2/neu 65 syngeneic 65 proto oncogene 65 glutamic acid decarboxylase 65 CC genotype 65 myeloperoxidase 65 adenocarcinomas 65 SOX9 65 constitutively expressed 65 EGFR inhibition 65 Jhdm2a 65 ERK1 2 65 subcellular localization 65 Akt activation 65 hypermethylated 65 FLT3 65 immunohistochemical staining 65 genes CYP#C# 65 S#A# [002] 65 Epidermal Growth Factor Receptor 65 Cathepsin B 65 HepG2 cells 65 Factor Receptor 65 multivariate Cox 65 PTEN gene 65 #q#.# [001] 65 HER2 gene 65 clusterin 65 Ki# 65 missense mutations 65 SNP rs# [002] 65 Foxp3 65 protein encoded 65 TNF α 65 gastric carcinoma 65 FUS1 65 hypereosinophilic syndrome 65 E#F# 65 EGFR tyrosine kinase inhibitors 65 CD#c 65 TNFalpha 65 IKZF1 65 heterozygotes 65 Pgp 65 microRNA expression 65 KRAS oncogene 65 intact parathyroid hormone 65 c MYC 65 upregulates 65 liver metastasis 65 SHANK3 65 B7 H3 65 CHD5 65 EGFRvIII 65 SOCS3 65 chemoresistant 65 CD# expression [001] 65 mucinous 65 EphB4 65 Fas ligand 65 MDR1 65 adrenoceptor 65 chronic eosinophilic leukemia 65 prostate carcinoma 65 Doxil ® 64 ERK signaling 64 progesterone receptor PR 64 p#Kip# 64 ADPKD 64 PKC inhibitor 64 CYP#C# [002] 64 germline mutations 64 antiangiogenic therapy 64 PDGFR 64 BRAF V#E mutation 64 estrogen receptor alpha 64 FGFR4 64 DNA hypermethylation 64 BCR ABL1 64 microglial activation 64 HER3 64 ovarian carcinoma 64 ErbB2 positive 64 progesterone receptor negative 64 hepatocellular carcinomas 64 Smad3 64 multivariate analyzes 64 PDGFRA 64 KRAS status 64 CYP#A# [002] 64 SIRT2 64 ASCUS 64 somatic mutation 64 proapoptotic 64 mosaicism 64 Upregulation 64 HER2 neu 64 Antitumor Activity 64 epithelial tumors 64 hepatic lipase 64 polycythemia vera PV 64 histologic subtypes 64 pegylated liposomal doxorubicin 64 rs# [002] 64 antiproliferative effects 64 Cyclin E 64 somatic mutations 64 EpCAM 64 Sipuleucel T 64 imatinib therapy 64 c Src 64 VEGF receptor 64 #F FDG PET 64 breast carcinomas 64 gemcitabine Gemzar 64 HCV replicon 64 monocyte chemoattractant protein 64 NF kB pathway 64 urine cytology 64 Immunohistochemical 64 metaplasia 64 HIF 1alpha 64 lactate dehydrogenase LDH 64 vWF 64 PIK3CA 64 dysbindin 64 downregulation 64 situ LCIS 64 ALK gene 64 LRAT 64 RASSF1A 64 colorectal carcinoma 64 WT1 64 mineralocorticoid 64 baseline LDH 64 murine models 64 HbF 64 differential gene expression 64 IgA deficiency 64 BRAF V#E 64 downregulated 64 TTR gene 64 p# MAPK 64 myopathies 64 sarcomatoid 64 H#K#me# 64 K ras gene 64 myeloproliferative diseases 64 ALDH 64 methylenetetrahydrofolate reductase 64 NFKBIA 64 melanocyte 64 receptor tyrosine kinase 64 Eg5 64 neuroblastoma tumors 64 survivin expression 64 chloride secretion 64 TSC1 64 thyrotropin 64 NKX#.# 64 neoadjuvant chemotherapy 64 FGFR2 64 pDCs 64 pharmacodynamic biomarkers 64 haematopoietic 64 CD# + [001] 64 LPS induced 64 p# mutation 63 KIT mutations 63 EGFr 63 EGFR HER2 63 GRP# 63 BRCA1 mutation carriers 63 hematological relapse 63 Gleevec resistant 63 liposomal doxorubicin 63 gefitinib Iressa 63 plasma pharmacokinetics 63 HLA DQ2 63 VEGF expression 63 splice variants 63 hepatoma 63 pretransplant 63 pT2 63 serum creatinine levels 63 LRP6 63 operable breast cancer 63 IGFBP2 63 neoplastic 63 homodimer 63 tipranavir ritonavir 63 GIST tumors 63 alkaline phosphatase ALP 63 rs# [001] 63 osteoblast 63 serum prostate 63 CIN2 + 63 HIF 1α 63 activating mutation 63 resistin 63 microvessel density 63 interferon γ 63 erlotinib Tarceva 63 receptor subtypes 63 DLC1 63 Fibroblast 63 TGFß 63 estrogen receptor progesterone receptor 63 immunohistochemical 63 transcriptional profiles 63 TP# mutations 63 EGFR expression 63 Lenalidomide 63 locoregional recurrence 63 PCa 63 CD4 + CD# 63 retinoic acid receptor 63 VEGFR1 63 CYP#D# gene 63 allelic 63 IFN α 63 estrogen receptor beta 63 PDGFR alpha 63 topo II 63 PTEN mutations 63 prognostic indicator 63 HER-2/neu 63 CD# expression [002] 63 SLC#A# [002] 63 ERa 63 flavopiridol 63 recurrent glioblastoma multiforme 63 papillary renal cell carcinoma 63 Leukemias 63 circulating endothelial cells 63 FDG-PET/CT 63 V#F mutation 63 radiosensitivity 63 Activating mutations 63 lymphocyte counts 63 hamartomas 63 MGMT gene 63 metalloproteinase 63 IFN gamma 63 IGF IR 63 phosphoprotein 63 biochemical relapse 63 castrate resistant 63 mutated KRAS 63 BCL#A 63 Mutational 63 Xanafide 63 annexin 63 ADAM# 63 TET2 63 CYP#A# CYP#D# 63 N cadherin 63 LHRH receptor positive 63 replicase 63 ESR1 63 melatonin receptor 63 IGF1R 63 tyrosine kinase receptor 63 5alpha reductase 63 CR nPR 63 missense mutation 63 adipogenic 63 pleiotropic 63 paricalcitol 63 uniparental 63 Janus kinase 63 Immunohistochemical staining 63 factor HGF 63 selectively inhibited 63 PDE#A 63 homodimers 63 transduced 63 clinicopathological features 63 eIF4E 63 caveolin 63 PC# cells 63 hMG 63 predictive biomarker 63 miR #b [001] 63 MAGE A3 ASCI 63 ribosomal protein 63 interferon IFN 63 IFN γ 63 imatinib resistant 63 Bcl XL 63 HER2 positive cancers 63 platelet reactivity 63 1beta 63 interleukin IL -# 63 CEACAM1 63 #p#.# [002] 63 pancreatic endocrine 63 xenograft models 63 GISTs 63 isoenzyme 63 HIF 1a 63 CDKN2A 63 gene loci 63 transcriptional repressor 63 PON1 63 Endometrial 63 cardiac troponin T 63 COX2 63 replicon 63 Tie2 63 AT1R 63 scintigraphic 63 EGFR inhibitors 63 IL #p# 63 constitutively activated 63 IL6 63 selective inhibition 63 progesterone receptor 63 independent prognostic marker 63 transactivation 63 downstream effectors 63 colon carcinoma 63 hydroxylase 63 chemokine receptor 63 biochemical abnormalities 63 Tumor Necrosis Factor 62 DNA methylation patterns 62 TMPRSS2 ERG 62 genetic polymorphisms 62 Leydig cell 62 CD#b 62 OvaRex MAb 62 annexin V 62 cytogenetic abnormalities 62 Supplementary Table 62 intratumoral injection 62 estramustine 62 Subgroup analysis 62 seminal vesicle invasion 62 APOC3 62 antibody titer 62 BRCA1 BRCA2 62 poor metabolizers 62 beta subunit 62 #p# [003] 62 irreversible inhibitor 62 Angiotensin converting enzyme 62 CagA 62 renal cysts 62 Bcl xL 62 ^ sup #m 62 breast cancer metastasis 62 antiangiogenic agent 62 TCF#L# 62 circulating EPCs 62 genetic polymorphism 62 CTNNB1 62 K RAS 62 pro angiogenic 62 neoadjuvant 62 potent inducer 62 OGG1 62 cis retinoic acid 62 mitogen activated protein kinase 62 CYP #D# 62 VEGFR2 62 PTHrP 62 F FDG PET 62 eNOS 62 CYP#D# genotype 62 heparanase 62 murine model 62 neuropilin 62 KIAA# 62 BRAF mutation 62 nodal metastasis 62 mineralocorticoid receptor 62 RT PCR assay 62 TGF β 62 MT1 MMP 62 sequence homology 62 p# activation 62 somatostatin receptors 62 ALB # 62 microglial 62 STK# [002] 62 MDM2 62 NQO1 62 IL #R 62 inactivating mutations 62 lymphocytosis 62 inducible nitric oxide synthase 62 renal fibrosis 62 ADAMTS# 62 CDK4 62 nicotinic receptor 62 JAK2 enzyme 62 GLI1 62 hTERT 62 somatostatin 62 micrometastases 62 serum concentrations 62 anaplastic lymphoma kinase ALK 62 transthyretin 62 perilipin 62 BRCA2 carriers 62 echocardiographic parameters 62 FGFR3 62 MAGE A3 62 mitogenic 62 endometrioid 62 HIV RNA 62 CD8 + 62 anti leukemic 62 K ras 62 Cytogenetic 62 5 HTTLPR 62 TrkB 62 RQ PCR 62 HOMA IR 62 pan HDAC inhibitor 62 familial aggregation 62 IGFBP 3 62 COL#A# 62 miRs 62 ErbB2 62 chromosomal aberrations 62 phenotypic expression 62 UGT#B# 62 nonmetastatic 62 leukocyte counts 62 APOL1 62 ligand induced 62 antiapoptotic 62 FGFR1 62 abnormal p# 62 squamous cell lung cancer 62 PLA2 62 promoter hypermethylation 62 CD3 + 62 pT3 62 TNFa 62 antitumor efficacy 62 #β estradiol 62 HNSCC 62 inhibitory receptor 62 Pharmacokinetics PK 62 serum cortisol 62 mediated apoptosis 62 p# mutations 62 FOLFOX6 62 MAPK pathway 62 imatinib resistance 62 catechol O methyltransferase 62 prostaglandin E 62 pDC 62 HAAH 62 mutant allele 62 Phosphorylation 62 periprocedural MI 62 Immunohistochemistry 62 transgene expression 62 Papillary 62 B7 H4 62 thrombin receptor 62 overexpressing 62 xenograft tumors 62 gene rearrangements 62 ERK pathway 62 VIPR2 62 Annexin V 62 cathepsin B 62 DNMT1 62 receptor gamma 62 P cadherin 62 P gp 62 KRAS mutation status 62 prognostic factor 62 TMPRSS2 ERG fusion 62 myelodysplastic myeloproliferative diseases 62 CCR2 62 Myeloid 62 TT genotype 62 SOD2 62 IDH1 mutation 62 elevated LDH 62 MMP# 62 airway hyperresponsiveness 62 albumin excretion rate 62 Tumor Response 62 downstream effector 62 node metastases 62 caveolin 1 62 BCR ABL 62 monocytic 62 imatinib Gleevec 62 adenylate cyclase 62 multikinase inhibitor 62 clinicopathological 62 leukocytosis 62 tumor subtypes 62 fallopian tube cancers 62 substrate specificity 62 muscarinic receptor 62 Neutrophil 62 EGFR TKIs 62 endocrine therapies 62 renal cell carcinomas 62 monocytes macrophages 62 FLT3 ITD 62 transcriptional regulation 62 invasive ductal 62 overexpressing cells 62 T#M 62 alpha subunit 62 HLA B# 62 microdeletions 62 β blockers 62 regulated kinase 62 SSc 62 autophagic 62 kDa protein 62 GSTT1 62 HBsAg 62 T2DM 62 ß catenin 62 Cytotoxic T 62 TAp# 62 serine threonine kinase 62 serotonin receptor 62 HBx 62 E cadherin expression 62 Erlotinib 62 GSTM1 62 seropositivity 62 kinase inhibition 61 advanced adenoma 61 tumor antigen 61 MUC1 61 viral kinetics 61 PGC 1α 61 Syk 61 KRAS gene 61 trans retinoic acid 61 intima media thickness 61 DQB1 * 61 FGFs 61 autoantibody 61 Kaplan Meier analysis 61 histologically 61 Allogeneic 61 biochemical recurrence 61 nitrotyrosine 61 TrkA 61 prospectively defined 61 wildtype 61 leukocyte count 61 thyroid peroxidase 61 chromosome #p# [002] 61 qRT PCR 61 muscarinic 61 taxane therapy 61 Vidaza ® 61 PC3 cells 61 Wwox 61 inhibin 61 mouse xenograft models 61 LKB1 61 CYP# [002] 61 Androgen receptor 61 glucokinase 61 prognostic indicators 61 cytopathic 61 EBMT criteria 61 polycythemia vera essential thrombocythemia 61 KRAS wild 61 micrometastasis 61 HLA DQ 61 Sjögren syndrome 61 p# biomarker 61 prognostic markers 61 NF kappaB activation 61 p#HER# 61 complete cytogenetic response 61 Lp PLA 2 61 NKG2D 61 GPNMB 61 UGT#A# * 61 serum albumin 61 61 PSADT 61 splice variant 61 invasive lobular 61 FOXP3 61 preoperative chemotherapy 61 Neoadjuvant 61 urothelial carcinoma 61 TMEM#B 61 LNCaP cells 61 bladder carcinoma 61 protein tyrosine phosphatase 1B 61 JAK2 V#F 61 dinucleotide 61 Ph + acute lymphoblastic 61 activin 61 MGUS 61 histone acetylation 61 Transgenic Mice 61 GBM tumors 61 protein tyrosine kinase 61 protein kinase C 61 tumor xenograft models 61 anti CD3 61 non squamous histology 61 p# INK4a 61 breast cancer subtypes 61 transcriptionally 61 Foxp3 + 61 EBNA1 61 CpG island 61 PI3K Akt 61 Squamous 61 bronchoalveolar lavage fluid 61 glucuronide 61 adrenocortical 61 Heterozygous 61 APOE genotype 61 transmembrane protein 61 anterior pituitary 61 P selectin 61 miRNA genes 61 fluvastatin 61 mutant p# 61 lymphomas leukemias 61 MMP2 61 serous ovarian cancer 61 genotypic resistance 61 mesothelin 61 mitoxantrone chemotherapy 61 Protein Kinase C 61 histologic subtype 61 preferentially bind 61 retinol binding protein 61 targeting CD# 61 myocardial infarct size 61 FGF2 61 functional polymorphism 61 Prognostic factors 61 receptor tyrosine kinase inhibitor 61 hypervascular 61 effector function 61 Stromal 61 neoplastic cells 61 poorer prognosis 61 thyroid hormone receptor 61 NFkB 61 HGPIN 61 dasatinib Sprycel 61 bcl 2 61 serum HBV DNA 61 soluble tumor necrosis 61 rheumatoid factor 61 virulence genes 61 gastrointestinal stromal tumor GIST 61 circadian genes 61 Solid Tumors criteria 61 estrogen receptor 61 log# copies mL 61 extramedullary 61 mammographic density 61 c fos 61 EGFR TKI 61 Macrophage 61 transiently transfected 61 HER2 ErbB2 61 pg ml 61 potent inhibition 61 plasma renin activity 61 Kinoid 61 PITX2 61 endoglin 61 hENT1 61 PEG IFN 61 TRAIL R1 61 Mutation Analysis 61 p# mitogen activated 61 XL# inhibits 61 aminotransferase 61 IGF 1R 61 glomerular 61 Enzastaurin 61 Genotypes 61 lesional 61 Pegylated 61 cardiac troponin 61 RECIST Response Evaluation Criteria 61 Fc gamma receptor 61 TGFBR1 * 6A 61 antiphospholipid antibodies 61 FGFR2 gene 61 cranial irradiation 61 humoral responses 61 EGF receptors 61 colocalization 61 induced apoptosis 61 specific antigen PSA 61 HER2 HER2 61 GNAQ 61 EGFR mutation 61 Prox1 61 JAK2 61 lupus anticoagulant 61 Modulates 61 Dysregulation 61 p# Shc 61 SOD1 gene 61 endothelial activation 61 potent antiproliferative 61 interleukin IL 61 demyelinating 61 EGFR receptor 61 poly ADP ribose polymerase 61 nmol liter 61 hyperalgesia 61 NMIBC 61 PTEN protein 61 allele frequencies 61 ACh 61 HMGCR 61 RNase L 61 hypothalamic pituitary 61 SGPT 61 hypermethylation 61 mononuclear 61 antisense inhibition 61 evolutionarily conserved 61 gene expression profiles 61 MTHFR gene 61 drug metabolizing enzymes 61 hydrolase 61 binds selectively 61 adiponectin concentrations 61 relapsed MM 61 troponin T 61 distant metastasis 61 5q 61 metastatic neuroendocrine tumors 61 monocyte chemotactic protein 61 lymphangiogenesis 61 lymphoid cells 61 NS4A 61 Flt3 61 PTP1B 61 transcriptional silencing 61 cystatin C 61 UGT#A# 61 5 HT2A 61 HLA DR 61 homozygotes 61 lactate dehydrogenase 61 pulmonary metastases 61 AMACR 61 IL 1ß 61 molecular biomarkers 61 CYP#D# 61 tumor specific antigen 61 de novo mutations 61 perfusion abnormalities 61 CXCL5 61 microsomal 61 familial ALS 61 Genetic variants 61 immunomodulation 61 Monocyte 61 Haptoglobin 61 tumor necrosis 61 chemopreventive agent 61 localized renal 61 MYCN 61 lymphoproliferative disorders 61 malignant prostate 61 resected pancreatic cancer 61 bronchial epithelial cells 61 TRAIL R2 61 differentially expressed genes 61 subependymal giant cell 61 #q# [001] 61 tumor biopsies 61 eotaxin 61 epithelia 61 leiomyoma 61 florbetaben 61 IgG antibody 61 paraneoplastic 61 colorectal adenocarcinoma 61 HMGA2 61 5 Fluorouracil 61 Estrogen receptor 61 hormone receptor negative 61 preoperative PSA 61 hypothalamic pituitary adrenal axis 61 surgically resected 61 metastatic lesions 61 leukemia AML 61 HLA DRB1 * 61 RANKL 61 intratumoral 61 univariate analysis 61 EGF receptor 61 FKBP# 61 Treg cell 61 transmembrane receptor 61 PALB2 61 Inactivation 61 kappa B 61 penetrance 61 skeletal metastases 61 proteoglycan 61 Polymorphisms 61 BDNF gene 61 Rab5 61 BCL2 61 bFGF 61 Histologic 61 Histone 61 gene locus 60 urocortin 60 pathogenic mutations 60 TRAIL Receptor 60 induces apoptosis 60 Brain derived neurotrophic 60 HBeAg 60 survivin 60 epigenetically 60 lung metastasis 60 leukocyte recruitment 60 Cx# [001] 60 methylated DNA 60 osteopenic 60 HDAC2 60 GLUT4 60 atypical hyperplasia 60 extracellular signal 60 TEL AML1 60 related apoptosis inducing 60 pharmacodynamic PD 60 STAT1 60 glucocorticoid receptor 60 HFE gene 60 mutated KRAS gene 60 molecular subtypes 60 FOXO1a 60 MLL2 60 NFAT 60 VNTR 60 trastuzumab Herceptin ® 60 MDA MB 60 seminomas 60 serum calcium levels 60 aggrecan 60 dopamine receptor gene 60 CHD7 60 logistic regression analysis 60 CYP#C# [001] 60 monozygotic twins 60 demonstrated antitumor activity 60 transgenic mouse models 60 eIF 4E 60 intronic 60 splenectomized patients 60 papillary RCC 60 Elevated serum 60 BRAF mutations 60 DEAR1 60 EGFR tyrosine kinase inhibitor 60 protease activated 60 TGF beta1 60 invasive carcinomas 60 HLA A2 60 gonadotrophin releasing hormone 60 K ras mutation 60 overactivation 60 aminotransferases 60 Topoisomerase II 60 SLITRK1 60 olfactory receptor 60 clinically meaningful differences 60 PAM4 60 bevacizumab Avastin ® 60 alkaline phosphatase